Different neural mechanisms underlie dizocilpine maleate- and dopamine agonist-induced locomotor activity

Neuroscience

Volumn 82, Issue 1, 1997, Pages 43-58

  Mele, A ^a   Thomas, D N ^b   Pert, A ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amphetamine; GABA; MK 801; Nucleus accumbens; Ventral pallidum

Indexed keywords

4 AMINOBUTYRIC ACID; AMPHETAMINE; APOMORPHINE; DIZOCILPINE; DIZOCILPINE MALEATE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; IBOTENIC ACID; MUSCIMOL; OXIDOPAMINE; SODIUM CHLORIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; GLOBUS PALLIDUS; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGONISTS; GLOBUS PALLIDUS; HYDROXYDOPAMINES; IBOTENIC ACID; MALE; MICRODIALYSIS; MOTOR ACTIVITY; MUSCIMOL; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; STIMULATION, CHEMICAL;

EID: 0030884963     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00277-7     Document Type: Article

References (68)

1. Al-Kathib I. M., Karadag H. C., Ulugol A. Behavioral effects of MK-801 injected into nucleus accumbens and caudate-putamen of rats. Pharmac. Biochem. Behav. 52:1995;723-730.
2. Bourdelais A., Kalivas P. Amphetamine lowers extracellular GABA concentration in the ventral pallidum. Brain Res. 516:1990;132-136.
3. Bourdelais A., Kalivas P. Apomorphine decreases extracellular GABA in the ventral pallidum of rats with 6-OHDA lesions in the nucleus accumbens. Brain Res. 577:1992;306-311.
4. Bowyer J. F., Spuhler K. P., Weiner N. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes. J. Pharmac. exp. Ther. 229:1984;671-680.
5. Bristow L. J., Huston D. H., Thorn L., Tricklebank M. D. The glycine/NMDA receptor antagonist, R(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclydine and dizocilpine (MK-801) in rodents. Br. J. Pharmac. 108:1993;1156-1163.
6. Burns L. H., Annett L., Kelley A. E., Everitt B. J., Robbins T. W. Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on reaction to novelty: implications for limbic-striatal interactions. Behav. Neurosci. 110:1996;60-73.
7. Carlsson M. L., Carlsson A. The NMDA antagonist MK-801 caused marked locomotor stimulation in monamine-depleted mice. J. neural Transm. 75:1989;221-226.
8. Carlsson M. L., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
9. Carlsson M. L., Svensson A. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmac. Biochem. Behav. 36:1989;45-50.
10. Clineschmidt B. V., Martin G. E., Bunting P. R., Papp N. L. Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro[a,d]cyclohepten-5,10-amine (MK-801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Dev. Res. 2:1982;135-145.
11. Criswell H. E., Johnson K. B., Mueller R. A., Breese G. R. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J. Pharmac. exp. Ther. 265:1993;1001-1010.
12. Dall'Olio R., Gandolfi O., Montanaro N. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonist in the rat. Psychopharmacology. 107:1992;591-594.
13. Fontana D. J., Post R. M., Pert A. Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. Brain Res. 629:1993;31-39.
14. Gandolfi O., Rimondini R., Dall'Olio R. The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms. Neuropharmacology. 31:1992;1111-1114.
15. Gattaz W. F., Schummer B., Behrens S. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats. J. neural Transm. (Gen. Sect.). 96:1994;227-232.
16. Hannigan J. H., Springer J. E., Isacson R. L. Differentiation of basal ganglia dopaminergic involvement in behavior after hippocampectomy. Brain Res. 291:1984;83-91.
17. Hiramatsu M., Cho A. K., Nabeshima T. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonist, MK-801, and phencyclidine. Eur. J. Pharmac. 166:1989;359-366.
18. Hondo H., Yanezawa Y., Nakahara T., Nakamura K., Hiramo M., Uchimura H., Tashiro N. Effects of phencyclidine on dopamine release in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res. 663:1994;337-342.
19. Imperato A., Scrocco M. G., Bacchi S., Angelucci L. NMDA receptors and in vivo release in the nucleus accumbens and caudatus. Eur. J. Pharmac. 187:1990;555-556.
20. Jackisch R., Link T., Neufang B., Koch R. Studies on the mechanism of action of the antiparkinsonian drugs memantine and amantadine: no evidence for direct dopaminomimetic or antimuscarinic properties. Archs Pharmacodyn. 320:1992;21-42.
21. Jaskiw G. E., Karoum F. K., Freed W. J., Phillips I., Kleinman J. E., Weinberger D. R. Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine induced locomotion and regional brain catecholamine concentration in the rat. Brain Res. 534:1990;263-272.
22. Jones D. L., Mogenson G. J. Nucleus accumbens to globus pallidus GABA projection: electrophysiological and iontophoretic investigations. Brain Res. 191:1980;93-105.
23. Jones D. L., Mogenson G. J. Nucleus accumbens to globus pallidus: GABA projections subserving ambulatory activity. Am. J. Physiol. 238:1980;R63-R69.
24. Kashihara K., Hamamura T., Okumura K., Otsuki S. Effect of MK-801 on endogenous dopamine release in vivo. Brain Res. 528:1990;80-82.
25. Kelley A. E., Domesick V. B. The distribution of the projection from hippocampal formation to the nucleus accumbens in the rat: an anterograde- and retrograde-horseradish peroxidase study. Neuroscience. 7:1982;2321-2335.
26. Kelley A. E., Domesick V. B., Nauta W. J. H. The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience. 7:1982;615-630.
27. Kelly P. H., Seviour P. W., Iversen S. D. Amphetamine and apomorphine responses in rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
28. Kiss J., Toth E., Lajtha A., Vizi E. S. NMDA receptors are not involved in the MK-801-induced increase of striatal dopamine release in rat: a microdialysis study. Brain Res. 641:1994;145-148.
29. Klockgether T., Turski L. NMDA antagonists potentiate antiparkinsionan actions of L-DOPA in monoamine-depleted rats. Ann. Neurol. 28:1990;539-546.
30. Lascher W., Hanock D. The behavioral effects of MK-801 in rats: involvement of dopaminergic, serotoninergic and noradrenergic systems. Eur. J. Pharmac. 215:1992;199-208.
31. Liljequist S., Ossowska K., Grabowska-Anden M., Anden N.-E. Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on metabolism of dopamine in various brain areas of mice. Eur. J. Pharmac. 195:1991;55-61.
32. Maj J., Rogoz Z., Skuza G. Locomotor hyperactivity induced by MK-801 in rats. Pol. J. Pharmac. Pharm. 43:1991;449-458.
33. Maldonado-Irizarry C. S., Kelley A. E. Differential behavioral effects following microinjection of an NMDA receptor antagonist into nucleus accumbens subregions. Psychopharmacology. 116:1994;65-72.
34. Marshall J. F., O'Dell S. J., Weihmuller F. B. Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J. neural Transm. 91:1993;241-254.
35. Mele A., Castellano C., Felici A., Cabib S., Caccia S., Oliverio A. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation. Eur. J. Pharmac. 308:1996;1-12.
36. Melega W. P., Williams A. E., Schmitz D. A., DiStefano E. W., Cho A. K. Pharmacokinetic and pharmacodynamic analysis of the actions of D-amphetamine and D-methamphetamine on dopamine terminals. J. Pharmac. exp. Ther. 274:1995;90-96.
37. Mogenson G. J., Nielsen M. A. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behav. neural Biol. 42:1984;38-51.
38. Morari M., O'Connor W. T., Ungerstedt U., Fuxe K. N-Methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of halothane-anesthetized rat: an in vivo microdialysis study. J. Neurochem. 60:1993;1884-1893.
39. Norton S., Mullenix P., Culver B. Comparison of the structure of hyperactive behavior in rats after brain damage from X-irradiation, carbon monoxide and pallidal lesions. Brain Res. 116:1976;49-67.
40. O'Neill K., Liebman J. M. Unique behavioral effects of the NMDA antagonist, CPP, upon injection into the medial pre-frontal cortex of rats. Brain Res. 435:1987;371-376.
41. Ouagazzal A., Amalric M. Competitive NMDA receptor antagonists do not produce locomotor hyperactivity by a dopamine dependent mechanism. Eur. J. Pharmac. 294:1995;137-146.
42. Ouagazzal A., Nieoullon A., Amalric M. Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats. Psychopharmacology. 111:1993;427-434.
43. Ouagazzal A., Nieoullon A., Amalric M. Locomotion activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Eur. J. Pharmac. 251:1994;229-236.
44. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
45. Pennatz C. M. A., Groenewegen H. J., Lopes Da Silva F. H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42:1994;719-761.
46. Pycock C., Horton R. Evidence for an accumbens-pallidal pathway in the rat and its possible gabaminergic control. Brain Res. 110:1976;629-634.
47. Raffa R. B., Ortegòn M. E., Robisch D. M., Martin G. E. In vivo demonstration of the enhancement of MK-801 by L-glutamate. Life Sci. 44:1989;1593-1599.
48. Rao T. S., Kim H. S., Lehemann J., Martin L. L., Wood D. L. Interactions of phencyclidine receptor agonist MK-801 with dopaminergic system: regional studies in the rat. J. Neurochem. 54:1990;1157-1162.
49. Rao T. S., Kim H. S., Lehemann J., Martin L. L., Wood D. L. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors. Neuropharmacology. 29:1990;225-230.
50. Rossetti Z. L., Hmaidan Y., Gessa G. L. Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur. J. Pharmac. 221:1992;227-234.
51. 3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding. J. Neurochem. 54:1990;1926-1933.
52. Scheel-Kruger J. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta neurol. scand. 73(Suppl.):1986;1-49.
53. Schwarcz R., Hockfeld T., Fuxe K., Jonsson G., Goldstein M., Terenius L. Ibotenic acid-induced neuronal degeneration: a morphological and neurochemical study. Expl Brain Res. 37:1979;199-216.
54. Sesack S. R., Pickel V. M. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons that are in apposition to each other. Brain Res. 527:1990;266-279.
55. Swanson L. W., Mogenson G. J., Gerfen C. R., Robinson P. Evidence for a projection from the lateral preoptic area and substantia innominata to the 'mesencephalic locomotor region' in the rat. Brain Res. 295:1984;161-178.
56. Swerdlow N. R., Amalric M., Koob G. F. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a presynaptic locus. Pharmac. Biochem. Behav. 26:1987;765-769.
57. Swerdlow N. R., Koob G. F. Neural substrates for the behavioral output of the nucleus accumbens. Life Sci. 35:1984;2537-2544.
58. Swerdlow N. R., Koob G. F. Separate neural substrates of the locomotor-activating properties of amphetamine, caffeine and corticotropine releasing factor (CRF) in the rat. Pharmac. Biochem. Behav. 23:1985;303-307.
59. Swerdlow N. R., Koob G. F. Lesions of dorsomedial nucleus of the thalamus, medial prefrontal cortex and pedunculopontine nucleus: effects on locomotor activity mediated by nucleus accumbens-ventral pallidal circuitry. Brain Res. 412:1987;233-243.
60. Swerdlow N. R., Swanson L. W., Koob G. F. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens. Brain Res. 306:1984;141-148.
61. Totterdell S., Smith A. D. Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. J. chem. Neuroanat. 2:1989;285-298.
62. Vezzani A., Serafini R., Stasi M. A., Caccia S., Conti I., Tridico R. V., Samanin R. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J. Pharmac. exp. Ther. 249:1989;278-283.
63. Whitton P. S., Biggs C. S., Pearce B. R., Fowler L. J. Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett. 142:1992;5-8.
64. Willins D. L., Narayanan S., Wallace L. J., Uretsky N. J. The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK-801. Pharmac. Biochem. Behav. 46:1993;881-887.
65. Wolf M. E., Dahlin S. L., Hu X.-L., Xue C.-J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.
66. Yang C. R., Mogenson G. J. Hippocampal signal transmission to the peduncolopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens; an electrophysiological and behavioral study. Neuroscience. 23:1987;1041-1055.
67. Yim C. Y., Mogenson G. J. Low doses of accumbens dopamine modulate amygdala suppression of spontaneous exploratory activity in rats. Brain Res. 477:1989;202-210.
68. Zahm D. S., Borg J. S. On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 50:1992;751-767.